Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergies
Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46
May 29th, 2009
Matrixx Initiatives, Inc. (NASDAQ:MTXX), an over-the-counter healthcare company that develops and markets Zicam(R) products that provide consumers with "better ways to get better(R)," announced financial results for its fourth quarter and fiscal year ended March 31, 2009. For the fiscal year ended March 31, 2009, net sales increased approximately 11%, to $111.6 million, compared to net sales of $101.0 million for the twelve months ended March 31, 2008. Additionally, net income increased approximately 33%, to $13.9 million, or $1.46 per diluted share, compared to net income of approximately $10.4 million, or $1.04 per diluted share, for the twelve months ended March 31,...
Source: Health Business Week (2009-05-29)
|
